Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 42.67 USD -1.16%
Market Cap: 2.5B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Protagonist Therapeutics Inc
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
Other Current Assets
$5.4m
CAGR 3-Years
-15%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.6B
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$3.1B
CAGR 3-Years
7%
CAGR 5-Years
-2%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$449.2m
CAGR 3-Years
-1%
CAGR 5-Years
21%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$412m
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
14%

See Also

What is Protagonist Therapeutics Inc's Other Current Assets?
Other Current Assets
5.4m USD

Based on the financial report for Sep 30, 2024, Protagonist Therapeutics Inc's Other Current Assets amounts to 5.4m USD.

What is Protagonist Therapeutics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
5%

Over the last year, the Other Current Assets growth was 31%. The average annual Other Current Assets growth rates for Protagonist Therapeutics Inc have been -15% over the past three years , 5% over the past five years .

Back to Top